Supportive care for patients with gynaecological cancer

  • Jean Klastersky Centre des Tumeurs de l’Université Libre de Bruxelles
  • Dominique Lossignol Centre des Tumeurs de l’Université Libre de Bruxelles
Keywords: gynaecological oncology, supportive therapy

Abstract

Close to 100000 new cases of invasive gynaecological malignancy are diagnosed each year, both in the United States and Western Europe, and account for about 30 000 deaths in either of these two geographical areas.1,2 Although many women will be cured eventually, most will require many months or years of treatment with major physical and psychological consequences, leading to substantial reduction in their quality of life (QOL).

Author Biographies

Jean Klastersky, Centre des Tumeurs de l’Université Libre de Bruxelles
MD, PhD Professor and Chief of Medicine (emeritus)Institut Jules Bordet Centre des Tumeurs de lUniversitLibre de Bruxelles
Dominique Lossignol, Centre des Tumeurs de l’Université Libre de Bruxelles
MD Head Supportive Care Unit Institut Jules Bordet Centre des Tumeurs de lUniversitLibre de Bruxelles
Published
2011-05-26
Section
Guest Editorial